ATE410433T1 - Siliciumverbindungen und deren verwendung - Google Patents
Siliciumverbindungen und deren verwendungInfo
- Publication number
- ATE410433T1 ATE410433T1 AT05820647T AT05820647T ATE410433T1 AT E410433 T1 ATE410433 T1 AT E410433T1 AT 05820647 T AT05820647 T AT 05820647T AT 05820647 T AT05820647 T AT 05820647T AT E410433 T1 ATE410433 T1 AT E410433T1
- Authority
- AT
- Austria
- Prior art keywords
- silicon compounds
- formulas
- therapy
- atom
- compound
- Prior art date
Links
- 150000003377 silicon compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/67—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/68—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/72—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0427722.4A GB0427722D0 (en) | 2004-12-17 | 2004-12-17 | Compounds and their uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE410433T1 true ATE410433T1 (de) | 2008-10-15 |
Family
ID=34090263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05820647T ATE410433T1 (de) | 2004-12-17 | 2005-12-16 | Siliciumverbindungen und deren verwendung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080261918A1 (de) |
| EP (1) | EP1824863B1 (de) |
| JP (1) | JP2008524193A (de) |
| KR (1) | KR20070097468A (de) |
| CN (1) | CN101107259A (de) |
| AT (1) | ATE410433T1 (de) |
| AU (1) | AU2005315331B2 (de) |
| BR (1) | BRPI0517047A (de) |
| CA (1) | CA2590881A1 (de) |
| DE (1) | DE602005010298D1 (de) |
| EA (1) | EA200701061A1 (de) |
| GB (1) | GB0427722D0 (de) |
| MX (1) | MX2007007319A (de) |
| WO (1) | WO2006064277A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7683058B2 (en) | 2005-09-09 | 2010-03-23 | H. Lundbeck A/S | Substituted pyrimidine derivatives |
| KR20080043314A (ko) * | 2005-09-09 | 2008-05-16 | 하. 룬트벡 아크티에 셀스카브 | 피리미딘 유도체 및 ｋｃｎｑ 포타슘 채널 개방제로서의그의 용도 |
| CN102971307A (zh) * | 2010-07-08 | 2013-03-13 | 辉瑞大药厂 | 作为kv7钾通道开放剂的哌啶基嘧啶酰胺 |
| EP3185881B1 (de) | 2014-08-26 | 2022-03-09 | Betanien Hospital | Verfahren, wirkstoffe und zusammensetzungen zur behandlung von entzündlichen erkrankungen |
| ES2746105T3 (es) * | 2014-10-08 | 2020-03-04 | Epigenetics Pharma Llc | Profármacos de 5-aza-pirimidina sililada útiles para tratar el cáncer |
| US11091447B2 (en) | 2020-01-03 | 2021-08-17 | Berg Llc | UBE2K modulators and methods for their use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60307313T2 (de) * | 2002-11-20 | 2006-12-14 | Paradigm Therapeutics Ltd. | Heterozyklische siliziumverbindungen und deren verwendung zur behandlung von krankheiten oder zuständen, die mit gnrh (gonadotropinfreisetzendem hormon) assoziiert sind |
| CA2531511A1 (en) * | 2003-07-10 | 2005-01-20 | Paradigm Therapeutics Ltd. | Silicon compounds and their use |
-
2003
- 2003-12-16 US US11/721,526 patent/US20080261918A1/en not_active Abandoned
-
2004
- 2004-12-17 GB GBGB0427722.4A patent/GB0427722D0/en not_active Ceased
-
2005
- 2005-12-16 KR KR1020077014460A patent/KR20070097468A/ko not_active Application Discontinuation
- 2005-12-16 MX MX2007007319A patent/MX2007007319A/es not_active Application Discontinuation
- 2005-12-16 BR BRPI0517047-8A patent/BRPI0517047A/pt not_active IP Right Cessation
- 2005-12-16 JP JP2007546194A patent/JP2008524193A/ja not_active Withdrawn
- 2005-12-16 DE DE602005010298T patent/DE602005010298D1/de not_active Expired - Fee Related
- 2005-12-16 EA EA200701061A patent/EA200701061A1/ru unknown
- 2005-12-16 CN CNA2005800432555A patent/CN101107259A/zh active Pending
- 2005-12-16 EP EP05820647A patent/EP1824863B1/de not_active Not-in-force
- 2005-12-16 CA CA002590881A patent/CA2590881A1/en not_active Abandoned
- 2005-12-16 WO PCT/GB2005/004905 patent/WO2006064277A1/en active Application Filing
- 2005-12-16 AU AU2005315331A patent/AU2005315331B2/en not_active Expired - Fee Related
- 2005-12-16 AT AT05820647T patent/ATE410433T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005315331A1 (en) | 2006-06-22 |
| JP2008524193A (ja) | 2008-07-10 |
| WO2006064277A8 (en) | 2007-10-11 |
| US20080261918A1 (en) | 2008-10-23 |
| EP1824863A1 (de) | 2007-08-29 |
| MX2007007319A (es) | 2008-03-07 |
| KR20070097468A (ko) | 2007-10-04 |
| EA200701061A1 (ru) | 2007-12-28 |
| BRPI0517047A (pt) | 2008-09-30 |
| DE602005010298D1 (de) | 2008-11-20 |
| CN101107259A (zh) | 2008-01-16 |
| CA2590881A1 (en) | 2006-06-22 |
| GB0427722D0 (en) | 2005-01-19 |
| WO2006064277A1 (en) | 2006-06-22 |
| AU2005315331B2 (en) | 2008-11-20 |
| EP1824863B1 (de) | 2008-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8649401A1 (es) | Analogos de anilino-pirimidina | |
| ATE410433T1 (de) | Siliciumverbindungen und deren verwendung | |
| CY1107846T1 (el) | Παραγωγα κιναζολινονης χρησιμα ως βανιλλοειδεις ανταγωνιστες | |
| TW200602808A (en) | Functionalized photoinitiators | |
| EA200501333A1 (ru) | 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ | |
| DE602006014367D1 (de) | Multimere von pyrimidinonderivaten und deren verwendung als inhibitoren der humanen neutrophilelastase | |
| MX2007005408A (es) | Compuestos de aminoquinazolinas. | |
| DE69910831D1 (de) | Epothilonderivate und ihre verwendung als antitumormittel | |
| NO20044995L (no) | Heterosykliske forbindelser | |
| NO20071922L (no) | Indazoler, benzisokazoler og benzinsotiazoler og anvendelse derav som ostrogene midler | |
| BRPI0513149A (pt) | uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito | |
| CY1109740T1 (el) | Νεα μεθοδος συνθεσης παραγωγων της 1,3,4,5 -τετραϋδρο-2η- 3-βενζαζεπιν-2-ονης και εφαρμογη στη συνθεση της ιβαβραδινης και των αλατων προσθηκης της σε ενα φαρμακευτικως αποδεκτο οξυ | |
| NO20085317L (no) | Imidazoazepinonforbindelser | |
| EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
| DE602005007241D1 (de) | 2-amino-benzimidazolderivate und ihre verwendung als modulatoren calciumaktivierter kaliumkanäle mit geringer leitfähigkeit | |
| DE602005010607D1 (de) | Zyklosporinanalog | |
| DE602004014628D1 (de) | Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren | |
| UY29141A1 (es) | Inhibidores de la adenilato ciclasa soluble | |
| TW200609228A (en) | Substituted n-acyl-2-aminothiazoles | |
| ATE371662T1 (de) | Siliziumverbindungen und deren verwendung | |
| DK1558580T3 (da) | N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner | |
| ATE332336T1 (de) | Azoverbindungen | |
| ATE407937T1 (de) | Rutheniumkomplexe mit antikrebswirkung | |
| BRPI0416708A (pt) | derivados de aminoquinazolidinadiona antibacterianos | |
| CO6150165A2 (es) | Nevos derivados 5,7-disustituidos de [1,3]tiazolo[4,5-d]pirimidin-2 (3h)-ona y su uso en terapia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |